Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones
Lo siento jejeje es que uno se excita en exceso con el nasdaq!!! Esto he encontrado sobre ZLCS:
Zalicus (ZLCS)
Buy Limit: $2. Target Price: $7 in 2012.
ZLCS has one technology for pain pathways, and another that develops combinations of approved drugs to combat diseases. How do they do it? The company’s high-tech assay equipment identifies synergistic combinations between already-existing drugs in an effort to better target diseases.
In spite of the failure of their first two drugs, they merged with privately-held Neuromed in a deal that is very beneficial for both sides. Exalgo for pain was approved in 2010, and that roll out plus additional partnership announcements in 2011 will drive the stock higher.
Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones
Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones
Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones
Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones
Sip, va a ser que se va a repetir el subidon de ultima hora del viernes.
Yo que estaba esperando a acumular mas mañana ... y va a ser mucho mas caro ...
Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones
Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones
Gracias por los datos de SNSS, me voy a cortar un brazo y lo paso todo a THLD